academic article

• Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease..  Parkinsonism & Related Disorders.  -. 2023
• Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies..  Neurotherapeutics.  20:375-388. 2023
• Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?.  BMC neurology.  21:-. 2021
• Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease..  Movement disorders : official journal of the Movement Disorder Society.  36:1871-1878. 2021
• Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease..  Age and ageing.  49:786-792. 2020
• Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes..  Movement disorders : official journal of the Movement Disorder Society.  35:1542-1549. 2020
• Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  29:35-47. 2020
• Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis..  Parkinsonism & related disorders.  96-102. 2019
• Readmissions after hospital care for meningitis in the United States..  American journal of infection control.  48:798-804. 2019